APA (7th ed.) Citation

S, A., A, R., AM, S., D, A., B, V. S., & P, S. (2021). REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS. Retina (Philadelphia, Pa.), 41(12), 2549. https://doi.org/10.1097/IAE.0000000000003244

Chicago Style (17th ed.) Citation

S, Al-Nawaiseh, Rickmann A, Seuthe AM, Al-Rimawi D, Viktor Stanzel B, and Szurman P. "REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS." Retina (Philadelphia, Pa.) 41, no. 12 (2021): 2549. https://doi.org/10.1097/IAE.0000000000003244.

MLA (9th ed.) Citation

S, Al-Nawaiseh, et al. "REVISED PREDICTIVE BIOMARKER FOR OCRIPLASMIN THERAPY IN VITREOMACULAR TRACTION DISORDERS." Retina (Philadelphia, Pa.), vol. 41, no. 12, 2021, p. 2549, https://doi.org/10.1097/IAE.0000000000003244.